(Q44213171)

30 November 2017

title

Comparative beneficial effects of simvastatin and pravastatin on cardiac allograft rejection and survival (English)

1 reference

30 November 2017

1 reference

1

1 reference

30 November 2017

8

Carl J Lavie

1 reference

30 November 2017

Patricia A Uber

2

1 reference

30 November 2017

Krishnamoorthy Vivekananthan

3

1 reference

30 November 2017

Sergio Solis

4

1 reference

30 November 2017

Robert L Scott

5

1 reference

30 November 2017

Myung H Park

6

1 reference

30 November 2017

Richard V Milani

7

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

Journal of the American College of Cardiology

30 November 2017

published in

1 reference

30 November 2017

volume

40

1 reference

30 November 2017

issue

9

1 reference

30 November 2017

page(s)

1609-1614

1 reference

Statins after cardiac transplantation: which statin, what dose, and how low should we go?

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902340-9

7 January 2021

Antiatherothrombotic properties of statins: implications for cardiovascular event reduction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902340-9

7 January 2021

Effect of pravastatin on outcomes after cardiac transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902340-9

7 January 2021

Efficacy and safety of pravastatin vs simvastatin after cardiac transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902340-9

7 January 2021

Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902340-9

7 January 2021

Predictive model to assess risk for cardiac allograft vasculopathy: an intravascular ultrasound study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902340-9

7 January 2021

Regulation of the mevalonate pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902340-9

7 January 2021

Direct vascular effects of HMG-CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902340-9

7 January 2021

3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase and Isoprenylation Inhibitors Induce Apoptosis of Vascular Smooth Muscle Cells in Culture

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902340-9

7 January 2021

Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902340-9

7 January 2021

The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902340-9

7 January 2021

Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902340-9

7 January 2021

Statins as a newly recognized type of immunomodulator

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902340-9

7 January 2021

Simvastatin attenuates vascular hypercoagulability in cardiac transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902340-9

7 January 2021

Simvastatin treatment is associated with improvement in coronary endothelial function and decreased cytokine activation in patients after heart transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902340-9

7 January 2021

Low-dose simvastatin is a well-tolerated and efficacious cholesterol-lowering agent in ciclosporin-treated kidney transplant recipients: double-blind, randomized, placebo-controlled study in 40 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902340-9

7 January 2021

10.1016/S0735-1097(02)02340-9

Identifiers

DOI

1 reference

30 November 2017

1 reference